147 related articles for article (PubMed ID: 22089351)
1. Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR.
Samija I; Mateša N; Lukač J; Kusić Z
Diagn Mol Pathol; 2011 Dec; 20(4):233-41. PubMed ID: 22089351
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions.
Matesa N; Samija I; Kusić Z
Cytopathology; 2007 Apr; 18(2):112-6. PubMed ID: 17397496
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.
Aratake Y; Umeki K; Kiyoyama K; Hinoura Y; Sato S; Ohno A; Kuribayashi T; Hirai K; Nabeshima K; Kotani T
Diagn Cytopathol; 2002 Jun; 26(6):366-72. PubMed ID: 12112826
[TBL] [Abstract][Full Text] [Related]
4. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
[TBL] [Abstract][Full Text] [Related]
5. [Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].
Wang LH; Zhao YJ; Wang XY; Yuan P; Xu WQ; Xiao JC; Xu JP; Luo BR
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):547-50. PubMed ID: 16438854
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules.
Gasbarri A; Martegani MP; Del Prete F; Lucante T; Natali PG; Bartolazzi A
J Clin Oncol; 1999 Nov; 17(11):3494-502. PubMed ID: 10550147
[TBL] [Abstract][Full Text] [Related]
7. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
[TBL] [Abstract][Full Text] [Related]
8. [Low galectin-3 capacity to discriminate thyroid lesions].
De-León-Mazariegos R; Canedo-Patzi M; Pérez-Enríquez B; Candanedo-Gonzalez F; Saqui-Salces M; Gamboa-Domínguez A; Rull-Rodrigo JA
Rev Invest Clin; 2004; 56(5):623-8. PubMed ID: 15776867
[TBL] [Abstract][Full Text] [Related]
9. [Detection of malignancy markers in thyroid nodules by reverse transcriptase polymerase chain reaction (RT-PCR)].
Pineda P; Rojas P; Liberman C; Moyano L; Goecke I
Rev Med Chil; 2003 Sep; 131(9):965-72. PubMed ID: 14635582
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Analysis of Galectin-3 Expression in Benign and Malignant Thyroid Nodules.
Šamija I; Mateša N; Tadinac S; Jukić T
Acta Clin Croat; 2020 Jun; 59(Suppl 1):25-31. PubMed ID: 34219881
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
[TBL] [Abstract][Full Text] [Related]
13. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
[TBL] [Abstract][Full Text] [Related]
14. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
[TBL] [Abstract][Full Text] [Related]
15. [The expression of galectin-3 in nodular thyroid goitre].
Chen WJ; Yu MH; Xu Y; Shen J
Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):452-5. PubMed ID: 16831319
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
17. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents.
Niedziela M; Maceluch J; Korman E
J Clin Endocrinol Metab; 2002 Sep; 87(9):4411-5. PubMed ID: 12213909
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
[TBL] [Abstract][Full Text] [Related]
20. Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors.
Umbricht CB; Conrad GT; Clark DP; Westra WH; Smith DC; Zahurak M; Saji M; Smallridge RC; Goodman S; Zeiger MA
Clin Cancer Res; 2004 Sep; 10(17):5762-8. PubMed ID: 15355904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
